Does APIXABAN Cause Facial paresis? 36 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Facial paresis have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.
36
Reports of Facial paresis with APIXABAN
0.0%
of all APIXABAN reports
3
Deaths
34
Hospitalizations
How Dangerous Is Facial paresis From APIXABAN?
Of the 36 reports, 3 (8.3%) resulted in death, 34 (94.4%) required hospitalization, and 15 (41.7%) were considered life-threatening.
Is Facial paresis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Facial paresis?
ONABOTULINUMTOXINA (478)
DEOXYCHOLIC ACID (129)
METHOTREXATE (89)
CYCLOPHOSPHAMIDE (68)
RIVAROXABAN (57)
RITUXIMAB (52)
ADALIMUMAB (48)
ASPIRIN (48)
BOTOX COSMETIC (45)
DOXORUBICIN (44)
Which APIXABAN Alternatives Have Lower Facial paresis Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ